Inventor · disambiguated record
Giovanni Cianchetta
Also filed as: CIANCHETTA GIOVANNI
21 granted patents·11 pending applications·160 citations·filing 2010–2024
95Inventor score
Files withAGIOS PHARMACEUTICALS INC18BI YINGZHI3LEXICON PHARMACEUTICALS INC3RECLUDIX PHARMA INC3CIANCHETTA GIOVANNI2
Top patents by PatentIndex Score
32 records- 0197US11040036B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·7 cites·26 claims
- 0297US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0396US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 0494US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 0592US9458132B2Therapeutic compounds and compositions and their use as PKM2 modulatorsAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 4, 2016·18 cites·25 claims
- 0691US9108921B2Therapeutic compounds and compositionsCIANCHETTA GIOVANNI·Filed 2014·Granted Aug 18, 2015·22 cites·8 claims
- 0790US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 0890US8946415B2Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their useBI YINGZHI·Filed 2013·Granted Feb 3, 2015·17 cites·15 claims
- 0989US11464775B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 1089US2025144093A1Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1188US11364240B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·27 claims
- 1286US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 1386US9403832B2Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·9 cites·6 claims
- 1486US8969565B2Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their useBI YINGZHI·Filed 2013·Granted Mar 3, 2015·11 cites·5 claims
- 1584US12133853B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·25 claims
- 1682US2023250078A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1781US11957680B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·0 cites·14 claims
- 1879US11872225B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·22 claims
- 1979US11590132B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·1 cites·24 claims
- 2069US2020079755A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2165US10000479B2Compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 19, 2018·1 cites·25 claims
- 2261US2025215030A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 2360US2025215029A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 2459US8304577B2Modulators of G protein-coupled receptor 88DZIERBA CAROLYN DIANE·Filed 2010·Granted Nov 6, 2012·1 cites·4 claims
- 2558US2025179103A16-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4h-pyrrolo[2,1-d][1,5]thiazocine derivatives as stat3 and stat6 modulators for the treatment of cancer and inflammatory conditionsRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 2655US2024276957A1Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulatorsAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2754US2016046579A1Therapeutic compounds and compositionsCIANCHETTA GIOVANNI·Filed 2014·Application pending·0 cites
- 2852US9365545B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·0 cites·31 claims
- 2948US2017129896A1PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXION PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3047US2017057964A1IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXICON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3144US2016024093A1IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXICON PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3234US8497271B2Modulators of G protein-coupled receptor 88BI YINGZHI·Filed 2010·Granted Jul 30, 2013·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Giovanni Cianchetta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →